Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database

Autor: Sylvestre Le Moulec, Nicholas Moore, Marie Pierrès, Patrick Blin, Marine Gross-Goupil, Mathieu Roumiguié, N. Thurin, Magali Rouyer, Jérémy Jové, Cécile Droz-Perroteau, Camille Capone, Xavier Rebillard, Emmanuelle Bignon, Stéphanie Lamarque, Michel Soulié, T. Haaser

Publikováno v: Cancer Epidemiology
Cancer Epidemiology, Elsevier, 2020, 69, pp.101833. ⟨10.1016/j.canep.2020.101833⟩
Cancer Epidemiology, 2020, 69, pp.101833. ⟨10.1016/j.canep.2020.101833⟩

International audience; Background: There is a lack of information about the burden of metastatic castration-resistant prostate cancer (mCRPC). The present work aims to estimate the incidence and prevalence of mCRPC in 2014 using the French nationwid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb92f97f79f653ebd864527aaafd1e9c
https://hal.archives-ouvertes.fr/hal-03116345

Survival outcome in patients with metastatic castration-resistant prostate cancer according to first-line treatment

Autor: Patrick Blin, Nicholas Moore, Marie Pierrès, Michel Soulié, N. Thurin, Marine Gross-Goupil, Stéphanie Lamarque, Camille Capone, Gérard de Pouvourville, T. Haaser, Emmanuelle Bignon, Jérémy Jové, Magali Rouyer, Cécile Droz-Perroteau, Xavier Rebillard

Publikováno v: Journal of Clinical Oncology. 38:5570-5570

5570 Background: Therapeutic strategy in metastatic castration-resistant prostate cancer (mCRPC) has evolved significantly with the introduction of abiraterone acetate in association with prednisone/prednisolone in first-line treatment in December 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef8f7cd30af986a1bbde62ab400152c6
https://doi.org/10.1200/jco.2020.38.15_suppl.5570